NCT04594980

Brief Summary

The purpose of this study is to determine the effectiveness of minimally invasive decompression and fusion over the traditional open decompression and fusion in patients with single-level lumbar stenosis caused by degenerative spondylolisthesis. Postoperative follow-up will continue for 12 months. Сlinical, safety, radiological and cost-effectiveness endpoints will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 20, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 3, 2026

Status Verified

March 1, 2026

Enrollment Period

2.1 years

First QC Date

October 10, 2020

Last Update Submit

March 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in Oswestry Disability Index (ODI)

    To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active

    3 months

Secondary Outcomes (16)

  • Change from baseline in Oswestry Disability Index (ODI)

    Through 2 years

  • Change from baseline in Numeric Pain Rating Score (NPRS)

    Through 2 years

  • Change from baseline in EuroQol Five-Dimensional descriptive system questionnaire (EQ-5D).

    Through 2 years

  • Change from baseline in Douleur Neuropathique 4 (DN4)

    Through 2 years

  • Change from baseline in The Health Transition Item from SF-36 (HTI Item)

    Through 2 years

  • +11 more secondary outcomes

Study Arms (2)

Minimally invasive TLIF

OTHER

Patients will undergo a single level decompression and fusion using a minimally invasive technique. Followed posterior screw fixation is mandatory.

Procedure: lumbar fusion

Open TLIF

OTHER

Patients will undergo a single level decompression and fusion using an open traditional technique. Followed posterior screw fixation is mandatory.

Procedure: lumbar fusion

Interventions

lumbar fusionPROCEDURE

Transforaminal Lumbar Interbody Fusion will be performed using minimally invasive approach or traditional open technique.

Minimally invasive TLIFOpen TLIF

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40-75 years;
  • Neurogenic claudication or bilateral radiculopathy caused by single level combination of degenerative stenosis and spondylolisthesis confirmed by MRI at one level L3-L4 or L4-L5 or L5-S1;
  • Symptoms persisting for at least three months prior to surgery;
  • Given written Informed Consent Form;
  • Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
  • Oswestry Disability Index score of at least 40/100 at baseline;

You may not qualify if:

  • Bilateral foraminal stenosis requiring surgical decompression on both sides;
  • Degenerative spondylolisthesis Type 2B, 3 subtypes by Gille;
  • More than one symptomatic level requiring multi-level surgical decompression and/or fusion;
  • Any condition that cannot be treated with mini-invasive unilateral decompression and fusion;
  • Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
  • Spondylolisthesis grade II or higher of any etiology;
  • Prior lumbar spinal fusion at any level;
  • Other non-degenerative spinal conditions that may have an impact on subject safety, wellbeing or the intent and conduct of the study;
  • History or presence of any other major neurological disease or condition that may interfere with the study assessments;
  • Severe arterial insufficiency of the legs or other peripheral vascular disease;
  • Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Priorov National Medical Research Center of Traumatology and Orthopedics

Moscow, 127299, Russia

Location

Related Publications (1)

  • Leonova ON, Cherepanov EA, Krutko AV. MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial. BMJ Open. 2021 Mar 5;11(3):e041134. doi: 10.1136/bmjopen-2020-041134.

MeSH Terms

Conditions

Spinal StenosisIntervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2020

First Posted

October 20, 2020

Study Start

January 20, 2022

Primary Completion

February 27, 2024

Study Completion

March 1, 2026

Last Updated

March 3, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Data are available upon reasonable request. Please contact the corresponding author for detail.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
During the study conducting and during 5 years after
Access Criteria
The approval of institutional review board will be necessary

Locations